Childhood Cancer

You are here

Home » Grants » All grants tagged with "Solid and Bone Cancers"

All grants tagged with "Solid and Bone Cancers"

Using Contrast Enhanced Ultrasound to Assess the Efficacy of Akt Inhibition as a Radiosensitizer in Experimental Neuroblastoma
Fauzia Shaikh
Columbia University Medical Center
POST Program Grants, Awarded 2013
FANCD2 as a Targetable Biomarker of Radiation Resistance in Pediatric Rhabdomyosarcoma
Nikhil Sebastian
The Ohio State University
POST Program Grants, Awarded 2013
Incidence and Outcomes of Clostridium Difficile in Pediatric Hematopoietic Stem Cell Transplant (HSCT) Recipients
Priya Prasad
University of California San Francisco
POST Program Grants, Awarded 2013
Pharmacodynamics (PD) Assay of Novel Ezrin Inhibitors on Osteosarcoma
Christina Kraus
Georgetown University
POST Program Grants, Awarded 2013
Analysis of the Deviations in the Diagnosis and Treatment Trajectories of Children with Cancer in Low-income Countries and Their Impact on Outcomes: A Comparative Study Between US and Guatemala
Lenka Ilcisin
Dana-Farber Cancer Institute
POST Program Grants, Awarded 2013
The Ion Channel TRPM2 is a Target to Enhance Chemosensitivity in Neuroblastoma
Brian Gans
The Pennsylvania State University
POST Program Grants, Awarded 2013
Targeting RNA Helicase DDX3 to Treat Recurrent High Grade Sarcoma
David Loeb, MD, PhD
The Johns Hopkins University School of Medicine
Reach Grants, Awarded 2013
Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma
Gerard Blobe, MD, PhD
Duke University Medical Center
Reach Grants, Awarded 2013
Preclinical Development of Targeted Therapy for Neuroblastoma with ALK and CDK4/6 Dual Pathway Inhibition
Yael Mossé, MD
Children’s Hospital of Philadelphia
Reach Grants, Awarded 2013
Moving EphB4 Therapeutics to Pediatric Phase I/II Trials
Charles Keller, MD
Oregon Health & Science University
Reach Grants, Awarded 2013

Pages

All childhood cancer types

Featured Hero

Ailani Myers

Ailani's family calls her a true Warrior Princess as she fights acute lymphoblastic leukemia. Doctors discovered Ailani harbored a rare genetic mutation which makes standard treatment ineffective. Today, Ailani has reached remission!
Read more »